|at ( view profile)|
|Date Posted||December 16, 2020|
|Address||1500 Highland Ave|
The Waisman Center is dedicated to the advancement of knowledge about human development, developmental disabilities, and neurodegenerative diseases throughout the lifespan. One of 14 centers of its kind in the United States, the Waisman Center encompasses laboratories for biomedical and behavioral research, a brain imaging center, and a clinical biomanufacturing facility for the production of pharmaceuticals for early stage human clinical trials. In addition to its research efforts, the Center provides an array of services to people with developmental disabilities, offers numerous educational and outreach programs to young children and their families, and trains scientists and clinicians who will serve our nation in the future.
This position will work within the Waisman Biomanufacturing (WB) work unit. WB is a clinical manufacturing facility that produces biologics (gene therapeutics, cell therapeutics, recombinant proteins and vaccines) for Phase I and II Human Clinical Trials in compliance with current Good Manufacturing Practice (cGMP) guidelines. WB's Quality Control (QC) team works with Manufacturing and Quality Assurance (QA) teams to test biopharmaceutical products and document results for in-process and final product release testing.
The Researcher will serve as a Subject Matter Expert (SME) and will provide technical expertise in the areas of cell therapies and large scale cell culture. This includes designing, developing and executing cell culture and upstream manufacturing processes to support the production of clinical trial materials for WB and its clients and new project-specific process development, assay development and manufacturing processes for the scale-up and manufacturing of biotherapeutics.
To apply, please visit https://jobs.hr.wisc.edu/en-us/job/506899/cell-therapy-manufacturing-subject-matter-expert